As suggested in animal research studies, PNC-27 is an engineered peptide with potential anti-cancer properties, suggested to eliminate cancer cells inside the organism. Attached to malignant cells, the PNC-27 peptide has been hypothesized to trigger cell
Britain's drugs regulator on Monday approved GSK's drug, Jemperli, to be used with chemotherapy for cancer of the womb lining as a first line treatment. Jemperli is now authorised to be used together with chemotherapy to slow the progression of endometrial cancers, increasing life expectancy for patients, the UK's Medicines and Healthcare products Regulatory Agency said.
Recent Data for PARP Inhibitors in Recurrent Ovarian Cancer onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.
Efficacy of Subsequent Therapies in Advanced Ovarian Cancer onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.
A comprehensive overview of recent clinical trial data on PARP inhibitors in the first-line maintenance setting in ovarian cancer presented at ASCO 2023.